In this webinar, we have two presentations showing the latest research on the implications for life and health insurers of two key issues: genomics and pandemic risk. Dr Peter Joshi and Paul Timmers will share their research on how well-established underwriting processes can allow for genomics in predicting expected mortality and morbidity. They will then discuss the potential for stratified screening and personalised medicine to improve health and reduce claim costs. Dr Gordon Woo, experienced catastrophist, will discuss the impact of ecological changes on pandemic risk. COVID-19 has concentrated actuarial attention on pandemics as being a key risk factor for insurers. Starting from a review of five near-miss dangerous infectious diseases of the first two decades of the 21st century, the ecological impact on pandemic risk will be assessed for the coming decades and insights presented on what this may mean for life and health actuaries.